Monday - December 22, 2025
FDA Issues Warning Letter to Wells Pharma of Houston
November 26, 2025
WASHINGTON, Nov. 26 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Wells Pharma of Houston LLC from the Center for Drug Evaluation and Research:

* * *

Recipient: Andrew C. Corbin, CEO/CFO, Wells Pharma of Houston, LLC, 9265 Kirby Drive, Houston, TX 77054-2520, United States

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING LETTER
< . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products